Cencora Forecasts Up to 10% Earnings Growth After Record Year
CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) projected adjusted earnings growth of 8% to 10% for fiscal 2027 after reporting $337.4 billion in annual revenue, as the pharmaceutical distributor expands …
Cencora Forecasts Up to 10% Earnings Growth After Record Year Read More